Hematological Cancers
Hematlogical cancers are maligancies that arise in the lymphatic system (blood, bone marrow, and lymph nodes) and account for 9-10% of new cancer cases in the United States. There are several classifications of hematalogical maligancies, which are typically broken down into 3 categories: leukemias, lymphomas, and myelomas.
The products below highlight some of the more frequent types of hematological cancers. Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer with two sub-types of the disease: B-cell ALL and T-cell ALL. Acute Myeloid Leukemia (AML) is the most common acute leukemia affecting adults and characterized by the rapid proliferation white blood cells in the bone marrow. Lymphoma is a large group of blood cell tumors with two main sub-categories: Hodgkin lymphoma and non-Hodgkin lymphoma. Multiple Myeloma is a cancer of the plasma cells affecting mostly elderly people. It is currently considered incurable, but there are many treatments to decrease the signs and symptoms.
Visit our disease specific pages to view more detailed information about hematological cancers, related genes, pathways, publications, and more.
 |
 |
 |
|
CD3 |
CD10 |
IL-6 |
